Cowden syndrome medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
**Preferred regimen (1): [[Acitretin]] 30 mg/day for [[cutaneous]] manifestations. | **Preferred regimen (1): [[Acitretin]] 30 mg/day for [[cutaneous]] manifestations. | ||
***Side effects: | ***Side effects: | ||
****Teratogenicity | ****[[Teratogenicity]] | ||
****[[Xerostomia|Dryness]] of the [[eyes]] | |||
****Dryness of the [[nose]] | |||
****Dryness of the [[lips]] | |||
****[[Dry mouth|Dryness]] of the [[mouth]] | |||
****Dryness of the [[skin]] | |||
*** | *** | ||
**[[Acitretin]] should be discontinued once the recurrence of skin [[Lesion|lesions]] are noted. | **[[Acitretin]] should be discontinued once the recurrence of skin [[Lesion|lesions]] are noted. |
Revision as of 12:55, 19 March 2019
Cowden syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cowden syndrome medical therapy On the Web |
American Roentgen Ray Society Images of Cowden syndrome medical therapy |
Risk calculators and risk factors for Cowden syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
Due to different phenotypes cowden syndrome is likely to be an underdiagnosed condition. Pharmacologic medical therapy is recommended among patients with cutaneous manifestations in cowden syndrome.
Medical Therapy
- Pharmacologic medical therapy is recommended among patients with cutaneous manifestations in cowden syndrome patients.
- Screening for multiple cancers should be effectively done in the patients with cowden syndrome.